ORCHIDPHAR

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2008.A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ORCHIDCHEM_LR_05032009.ZIP target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that in terms of the provisions of Section 192A of the Companies Act, 1956 read with the Companies (Passing of the Resolution by Postal Ballot) Rules, 2001, to seek the approval of members through Postal Ballot for passing the following Resolutions as ordinary resolutions; 1) Increase in Borrowing Limits, 2) Creation of Mortgages and Charges. The Board of Directors at their meeting held on January 28, 2009 has decided to seek the approval of the shareholders by way of postal ballot and for this purpose has appointed Mrs. S. Lalit

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated January 28, 2009, titled "Orchid registers turnover of Rs.310 crore during Q3 FY09 Maintains operational profitability (PBT) at Rs.28 crore; Earnings for the quarter ended December 31, 2008 (Q3 FY09)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/orchid_PR_28012009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 29527.51 lacs for quarter ending on 31-DEC-2008 against Rs. 33268.9 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. (630.62) lacs for the quarter ending on 31-DEC-2008 against Rs. 5411.73 lacs for the quarter ending on 31-DEC-2007.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated January 16, 2009, titled "Orchid receives US FDA approval for Levetiracetam Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_16012009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a media release dated December 04, 2008 titled "Orchid receives US FDA approval for Divalproex Sodium DR tablets". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). <a href=/content/corporate/OrchidChem_PR_04122008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the auditor's have conducted the limited review of the Un-audited financial results for the period ended September 30, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_LR_14112008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the press release dated October 30, 2008, titled "Orchid's revenue during Q2FY09 rises by 18.7% to Rs. 348.45 crore; Achieves Salient progress in the Generics and R & D Verticals". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_30102008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the standalone Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 62169.14 lacs for half year ending on 30-SEP-2008 against Rs. 53332.62 lacs for the half year ending on 30-SEP-2007. Net Profit / (Loss) of Rs. (7230.64) lacs for the half year ending on 30-SEP-2008 against Rs. 11457.07 lacs for the half year ending on 30-SEP-2007.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 33914.02 lacs for quarter ending on 30-SEP-2008 against Rs. 29512.98 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. (4066.05) lacs for the quarter ending on 30-SEP-2008 against Rs. 6327.26 lacs for the quarter ending on 30-SEP-2007.

Orchid Chemicals & Pharmaceuticals Ltd has submitted to the Exchange a copy of Proceedings of the Annual General Meeting of the Company held on September 29, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ORCHID_AGM_24102008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated October 16, 2008, titled "Orchid receives US FDA approvals for three Cefuroxime Inj. ANDAs". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_16102008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that "Dr Anzaghi Piergiorgio, Director has resigned from the Board of Orchid Chemicals & Pharmaceuticals Limited with effect from October 3, 2008".

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated September 29, 2008, titled "Orchid & Merck & Co., Inc. collaborate to develop novel anti-infective drugs". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_29092008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that: "Industrial Development Bank of India has withdrawn the nomination of Shri S Andi and instead appointed Shri S Jeyakumar, General Manager, Infrastructure Corporate Group, Industrial Development Bank of India Limited, Mumbai as its nominee on the Board of Orchid Chemicals & Pharmaceuticals Limited with effect from September 08, 2008".

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the Allotment Committee of the Board of Directors of the Company at their meeting held on August 29, 2008 have allotted 41,79,000 equity shares of Rs. 10 each at a price of Rs. 202.58 per share pursuant to conversion of warrants by the persons in Promotor/Promotor Group. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). <a href=/content/corporate/Orchid_Allotment_29082008.zip target

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the Annual General Meeting of the Company is scheduled to be held on September 29, 2008. Further, the dates of closure of Register of Members for the purpose of Annual General Meeting and for payment of dividend has been fixed by the Board from September 20, 2008 to September 29, 2008 (both days inclusive).

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that auditor's have conducted the limited review of the Un-audited financial results (provisional) for the quarter ended June 30, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_LR_20082008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that "The Allotment Committee of the Board of Directors of Orchid Chemicals and Pharmaceuticals Limited at their meeting held on August 13, 2008 have allotted 385000 equity share of Rs. 10 each as per particulars given below: (1) 381000 equity shares of Rs. 10 each in favour of R. Sowmya at a price of Rs. 202.58 per share pursuant to conversion of warrants granted to Promoter/Promoter Group. These equity shares would be subject to lock-in till February 28, 2010. (2) 3000 equity shares of Rs. 10 each in favour R. Narayanan, Chairm

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the press release dated August 13, 2008, titled "Orchid to develop Novel Anticoagulant Drug Candidate from Merck". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_14082008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the press release dated August 04, 2008, titled "Orchid receives EU approvals for Piperacillin Tazobactam injection". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_04082008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated July 30, 2008, titled "Orchid's Q1 FY09 income grows 30%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_30072008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 28765.92 lacs for quarter ending on 30-JUN-2008 against Rs. 23819.64 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. (3164.6) lacs for the quarter ending on 30-JUN-2008 against Rs. 5129.8 lacs for the quarter ending on 30-JUN-2007.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 30993.43 lacs for quarter ending on 30-JUN-2008 against Rs. 25176.97 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. (3384.8) lacs for the quarter ending on 30-JUN-2008 against Rs. 4858.94 lacs for the quarter ending on 30-JUN-2007.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated June 24, 2008, titled, "Orchid receives Canadian approval for Piperacillin Tazobactam injection". The copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_24062008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the Allotment Committee of the Board of Directors of the Orchid Chemicals & Pharmaceuticals Limited at their meeting held on May 29, 2008 have allotted 16,375 equity share of Rs. 10 each as per particulars given below : 1) 16,175 equity shares of Rs. 10 each (16,150 equity shares at an adjusted price of Rs. 200.44 per share and 25 equity shares at a revised price of Rs. 193.25 per share) to the employees under ESOP 1999 Scheme and 2) 200 equity shares of Rs. 10 each at a price of Rs. 193.25 per share to the employees under E

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated May 29, 2008, titled "Orchid's FY08 turnover rises by 36% to Rs.1239 crore; Net profit records a growth of 91%; Board recommends dividend of 30%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_29052008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the Board of Directors of the Company at its meeting held on May 29, 2008 has recommended a dividend of 30% (Rs.3/- per share) on the equity share of Rs.10/- each.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 37919.36 lacs for quarter ending on 31-MAR-2008 against Rs. 24800.11 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 1584.81 lacs for the quarter ending on 31-MAR-2008 against Rs. 2426.67 lacs for the quarter ending on 31-MAR-2007.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 123891.62 lacs for year ending on 31-MAR-2008 against Rs. 93417.55 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 18453.61 lacs for the year ending on 31-MAR-2008 against Rs. 9663.18 lacs for the year ending on 31-MAR-2007.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 130096.39 lacs for year ending on 31-MAR-2008 against Rs. 98508.07 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 17533.99 lacs for the year ending on 31-MAR-2008 against Rs. 7859.64 lacs for the year ending on 31-MAR-2007.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the Compensation Committee of the Board, has revised by increasing the exercise period of options granted under ORCHID - ESOP 1999 and ORCHID - ESOP 2005 Schemes to 3 years from the date of vesting.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the Allotment Committee of the Board of Directors of the Company at their meeting held on April 26, 2008 have allotted 9,425 equity share of Rs. 10 each as per particulars given below : 1) 7,525 equity shares of Rs. 10 each (7,400 equity shares at an adjusted price of Rs. 200.44 per share and 125 equity shares at a price of Rs. 193.25 per share) to the employees under ESOP 1999 Scheme and 2) 1,900 equity shares of Rs. 10 each at a price of Rs. 193.25 per share to the employees under ESOP 2005 Scheme. The above equity shares

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the company will be publishing the audited financial results for the year ended March 31, 2008 within a period of 3 months, i.e. on or before June 30, 2008.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated April 22, 2008, titled "Ranbaxy and Orchid announce strategic business alliance - To leverage respective strengths for mutually beneficial business growth". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_22042008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a media release dated April 10, 2008, titled "Orchid announces the formation of its Japanese Subsidiary, Orchid Pharma Japan KK - To drive foray into the growing high potential Japanese generics market". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_MR_10042008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the Press Release dated March 18, 2008 titled " Orchid Chemicals clarifies on market fall of its shares". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/orchid_PR_18032008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated February 20, 2008, titled "Orchid receives US FDA approval for Cefuroxime Axetil ANDA ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_20022008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated February 14, 2008, titled "Orchid receives USFDA nod for Granisetron generic formulation First Indian company to be approved for this non-antibiotic product". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/OrchidChem_PR_14022008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated February 08, 2008, titled "Orchid ropes in Dr Gopalan to head its Drug Discovery initiatives; To head Orchid Research Labs as CSO & Director". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_08022008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that : "Dr Bishwajit Nag, Director has resigned from the Board of Orchid Chemicals & Pharmaceuticals Limited with effect from February 04, 2008".

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated January 17, 2008, titled "Orchid's Q3 FY08 revenue up by 39% to Rs 333 crore; Net Profit rises by 91% to Rs. 54 crore". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_17012008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 33268.9 lacs for quarter ending on 31-DEC-2007 against Rs. 23873.33 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 5411.73 lacs for the quarter ending on 31-DEC-2007 against Rs. 2832.35 lacs for the quarter ending on 31-DEC-2006.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated January 11, 2008, titled "Orchid's formulation facilities receive MCC (South Africa) nod Cephalosporin & Penicillin Injectable facilities approved". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_11012008.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that : "The Allotment Committee of the Board of Directors at its meeting held on December 20, 2007 have allotted 3000 equity Shares of Rs. 10/-each to Shri R. Narayanan, Director under ORCHID-ESOP99 Scheme".

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated November 16, 2007, titled "Orchid receives US FDA approval for Cefpodoxime Proxetil ANDA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Orchid_PR_16112007.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a press release dated October 18, 2007, titled "Orchid's Q2 FY08 revenue higher by 20% at Rs 295 crore ; Net profit jumps 115% to Rs 63 crore". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/orchid_PR_181007.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that: "The Allotment Committee of the Board has allotted shares as follows: (1) 5650 shares at an adjusted price of Rs.200.44 per share to employees under ORCHID ESOP 1999 Scheme on July 17, 2007. (2) 6000 shares at an adjusted price of Rs.200.44 per share to employees under ORCHID ESOP 1999 Scheme on October 18, 2007".

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 29512.98 lacs for quarter ending on 30-SEP-2007 against Rs. 24573.13 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 6327.26 lacs for the quarter ending on 30-SEP-2007 against Rs. 2945.08 lacs for the quarter ending on 30-SEP-2006.

Orchid Chemicals & Pharmaceuticals Ltd has submitted to the Exchange a copy of the Proceedings of the Annual General Meeting of the Company held on July 19, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/OrchidChemicalsPharma_AGMProceedings.zip target=NEW> For more details click here.</a>